ArticlePostepy dermatologii i alergologii2026
Dual therapy with minocycline and itraconazole as a new treatment option for recurrent dermatophytosis.
Article in Postepy dermatologii i alergologii, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Recurrent dermatophytosis presents a clinical dilemma for patients and dermatologists. These cases often have a chronic and inflammatory nature and are resistant to commonly used antifungal drugs. Numerous treatment options have been proposed to address this problem. Aim: This study aimed to evaluate the effectiveness of combining minocycline with itraconazole in the treatment of recurrent widespread dermatophytosis. Material and methods: A prospective clinical trial was conducted on 86 patients with recurrent extensive dermatophytosis. All patients received a daily dose of 100 mg itraconazole and 80 mg minocycline orally for two-six/2-6 weeks. The patients were closely monitored every 2 weeks until they achieved a complete cure. They were followed up for 3 consecutive months and instructed to return if they experienced any signs of recurrence. Results: This study included 86 patients aged between 18 and 65 years with recurrent dermatophytosis. Conclusions:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.